Work

Interview with Dr. Tuveson from nab-Paclitaxel Potentiates Gemcitabine Activity by Reducing Cytidine Deaminase Levels in a Mouse Model of Pancreatic Cancer

Year: 2023

Type: editorial

Abstract: mp3 file (10 MB). In the March edition of the Cancer Discovery podcast, Executive Editor Mark Landis talks with David A. Tuveson about his paper, which provides mechanistic insight into the clinical cooperation observed between gemcitabine and nab-paclitaxel in the treatment of pancreatic cancer.

DOI: 10.1158/2159-8290.22532768.v1

Authors: Kristopher K. Frese, Albrecht Neesse, Natalie Cook, Tashinga E. Bapiro, Martijn P. Lolkema, Duncan I. Jodrell, David A. Tuveson

Language: English

Topic: Pancreatic and Hepatic Oncology Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4362481306

Cites:

Cited by:

Related to: 10